Networks

Novasecta creates networks that actively foster and deepen relationships between senior pharmaceutical executives.

Novasecta has a particularly deep understanding of, and strong heritage in, MidPharmas. These companies are often family or foundation controlled and typically have annual revenue of between €50 million and €5 billion. They are tremendously diverse, just like the European countries in which they are based. These companies are not so large as to be cumbersome, nor so small as to be dependent on a single project for their survival. We have specialised in these companies since we were first established. Read more about MidPharmas in our 2014 invited commentary in MedNous.

Each year, we host invitation-only meetings for senior management of these companies, as well as open, informal roundtable discussions. To date, over 200 senior pharma/biotech executives have participated in our private meetings.


Private Pharma R&D Meeting

  • Annual multi-company meeting initiated in 2006 for R&D leaders such as Heads of R&D, Discovery or Development.
  • Involves a networking dinner and a full day of interactive discussions seeded by peer case examples and/or Novasecta research and experience.

Click here for more information on the 2016 R&D meeting.


Private Pharma Corporate Development Meeting

  • Annual multi-company meeting initiated in 2003 for CEOs and Heads of Strategy, Corporate Development and/or Business Development.
  • Involves a networking dinner and a full day of interactive discussions seeded by peer case examples and/or Novasecta research and experience.

Click here for more information on the 2015 Corporate Development meeting.